Regulus Therapeutics Inc (RGLS)
2.27
+0.01
(+0.44%)
USD |
NASDAQ |
May 31, 16:00
2.295
+0.02
(+1.10%)
After-Hours: 20:00
Regulus Therapeutics Gross Profit (TTM)
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2014 | 8.904M |
| June 30, 2014 | 13.94M |
| March 31, 2014 | 17.96M |
| December 31, 2013 | 19.57M |
| September 30, 2013 | 17.35M |
| Date | Value |
|---|---|
| June 30, 2013 | 14.04M |
| March 31, 2013 | 12.59M |
| December 31, 2012 | 12.70M |
| September 30, 2012 | 12.82M |
| June 30, 2012 | 13.82M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| ACADIA Pharmaceuticals Inc | 750.88M |
| Cassava Sciences Inc | -- |
| Vertex Pharmaceuticals Inc | 8.847B |
| Cormedix Inc | -0.8185M |
| Oragenics Inc | -- |